Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 6/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | TTR | P02766 | 1/20 | 0.51 |
| ▸ | PPOX | P50336 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | PPARD | Q03181 | 5/20 | 0.47 |
| ▸ | PPARA | Q07869 | 4/20 | 0.47 |
| ▸ | MRGPRX4 | Q96LA9 | 6/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10589748 | 0.86 | FFAR1 (0.50) | FFAR1MEN1TTRPPOXKMT2A | |
| SCHEMBL9711441 | 0.86 | FFAR1 (0.54) | FFAR1MEN1TTRPPOXKMT2A | |
| SCHEMBL8874528 | 0.84 | FFAR1 (0.64) | FFAR1MEN1TTRPPOXKMT2A | |
| SCHEMBL8378906 | 0.79 | FFAR1 (0.62) | FFAR1MEN1TTRPPOXKMT2A | |
| SCHEMBL204622 | 0.79 | FFAR1 (0.58) | FFAR1MEN1TTRPPOXKMT2A | |
| SCHEMBL8918684 | 0.79 | FFAR1 (0.58) | FFAR1MEN1TTRPPOXKMT2A | |
| SCHEMBL15635194 | 0.79 | FFAR1 (0.53) | FFAR1MEN1TTRPPOXKMT2A | |
| SCHEMBL6238335 | 0.78 | FFAR1 (0.51) | FFAR1MEN1TTRPPOXKMT2A | |
| SCHEMBL150103 | 0.78 | FFAR1 (0.58) | FFAR1MEN1TTRPPOXKMT2A | |
| SCHEMBL10518526 | 0.78 | FFAR1 (0.74) | FFAR1MEN1TTRPPOXKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311740-A1 | IMIDAZOPYRIDINE DERIVATIVES AS ACID PUMP ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2010-12-09 | — | — | US | claimed |
| US-5695773-A | APPLYING ONTO PLANT A DILUENT AND A SOLUTION CONSISTING OF OXYNIL AND A HERBICIDE IN LIQUID STATE | CFPI AGRO (FR) | 1997-12-09 | — | — | US | claimed |
| US-20100311592-A1 | USE OF 2-IODO-N 4-METHOXY-6-METHYL-1,3,5-TRIAZINE-2-YL CARBAMOYL BENZENESULFONAMIDE AND/OR SALTS THEREOF FOR COMBATING UNDESIRED PLANT GROWTH IN SELECTED USEFUL PLANT CROPS OR NON-CULTIVATED LAND | BAYER CROPSCIENCE AG (DE) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311592-A1 | USE OF 2-IODO-N 4-METHOXY-6-METHYL-1,3,5-TRIAZINE-2-YL CARBAMOYL BENZENESULFONAMIDE AND/OR SALTS THEREOF FOR COMBATING UNDESIRED PLANT GROWTH IN SELECTED USEFUL PLANT CROPS OR NON-CULTIVATED LAND | PFAS, INMT, GYS2 | FFAR1 2814/4885MEN1 2988/4885TTR 1065/4885 |
| US-20100311740-A1 | IMIDAZOPYRIDINE DERIVATIVES AS ACID PUMP ANTAGONISTS | HRH2, GIPR, MLNR | FFAR1 647/4885MEN1 4455/4885TTR 4779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.